Publicación: SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes
dc.contributor.author | Garay Montalvo, Evelin | |
dc.contributor.author | Serrano Coll, Héctor Alejandro | |
dc.contributor.author | Rivero, Ricardo | |
dc.contributor.author | Gastelbondo Pastrana, Bertha Irina | |
dc.contributor.author | Faccini Martínez, Álvaro Adolfo | |
dc.contributor.author | Berrocal, José | |
dc.contributor.author | Pérez, Alejandra | |
dc.contributor.author | Badillo, María | |
dc.contributor.author | Martínez Bravo, Caty Milena | |
dc.contributor.author | Botero, Yesica | |
dc.contributor.author | Arrieta Bernate, Germán Javier | |
dc.contributor.author | Calderón Rangel, Alfonso | |
dc.contributor.author | Galeano Anaya, Ketty Esther | |
dc.contributor.author | López Mejía, Yesica Paola | |
dc.contributor.author | Miranda Regino, Jorge Luis | |
dc.contributor.author | Guzmán Terán, Camilo Antonio | |
dc.contributor.author | Contreras Cogollo, Veronica | |
dc.contributor.author | Arosemena, Alejandra | |
dc.contributor.author | Contreras, Héctor | |
dc.contributor.author | Brango Tarra, Eimi Johana | |
dc.contributor.author | Oviedo Pastrana, Misael Enrique | |
dc.contributor.author | Mattar Velilla, Ameth Salim | |
dc.contributor.corporatename | Corporación Universitaria del caribe - CECAR | |
dc.contributor.researchgroup | Salud Pública y Auditoría en Salud | |
dc.date.accessioned | 2025-08-28T15:41:01Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Background: Serological evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an alternative that allows us to determine the prevalence and dynamics of this infection in populations. The goal of this study was to determine the clinical and sociodemographic dynamics of SARS-CoV-2 infection in a region of the Colombian Caribbean. Methods: Between July and November 2020, a cross-sectional observational study was carried out in Córdoba, located in northeast Colombia in the Caribbean area. Eight municipalities with the largest populations were chosen and 2564 blood samples were taken. A commercial enzyme-linked immunosorbent assay was used with the recombinant protein antigen N of SARS-CoV-2. The people included in the study were asked for sociodemographic and clinical data, which were analysed by statistical methods. Results: A seroprevalence of 40.8% was obtained for SARS-CoV-2 in the Córdoba region. In the bivariate analysis, no differences were observed in seropositivity against SARS-CoV-2 for gender or age range (p>0.05). Higher seropositivity was found in low socio-economic status and symptomatic patients (p<0.0001). A total of 30.7% of the asymptomatic patients were seropositive for SARS-CoV-2, which could be linked to the spread of this infection. In the multivariate analysis, seroconversion was related to poverty and clinical manifestations such as anosmia and ageusia (p<0.05). Conclusions: The high seropositivity in Córdoba is due to widespread SARS-CoV-2 in this population. The relationship between seropositivity and socio-economic status suggests a higher exposure risk to the virus caused by informal economic activities in low-income groups. Clinical manifestations such as anosmia and ageusia could be clinical predictors of infection by the new emergent coronavirus. | |
dc.description.researcharea | Auditoría en Salud | |
dc.description.researcharea | Salud Pública | |
dc.format.extent | 9 páginas | |
dc.format.mimetype | application/pdf | |
dc.identifier.eissn | 1878-3503 | |
dc.identifier.uri | https://repositorio.cecar.edu.co/handle/cecar/10786 | |
dc.language.iso | eng | |
dc.publisher.place | Colombia | |
dc.relation.citationendpage | 147 | |
dc.relation.citationstartpage | 139 | |
dc.relation.ispartofjournal | Transactions Royal Society of Tropical Medicine and Hygiene | |
dc.relation.references | Reina J. El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo. Vacunas. 2020;21(1):17–22. | |
dc.relation.references | Noor AU, Maqbool F, Bhatti ZA, et al. Epidemiology of CoViD-19 pandemic: recovery and mortality ratio around the globe. Pak J Med Sci. 2020;36(COVID-19-S4):S79–84. | |
dc.relation.references | Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res. 2020;7(1):1–10. | |
dc.relation.references | Capobianco G, Saderi L, Aliberti S, et al. COVID-19 in pregnant women: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:543–58. | |
dc.relation.references | World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Available from: https://covid19.who.int/ [accessed 3 March 2021]. | |
dc.relation.references | Ministerio de Salud y Protección Social. Coronavirus (COVID-19). Reportes y Tableros de Control. Available from: https://www.minsalud. gov.co/salud/publica/PET/Paginas/Covid-19_copia.aspx [accessed 18 May 2021]. | |
dc.relation.references | Nikolai LA, Meyer CG, Kremsner PG, et al. Asymptomatic SARS coronavirus 2 infection: invisible yet invincible. Int J Infect Dis. 2020;100:112–6. | |
dc.relation.references | Percivalle E, Cambiè G, Cassaniti I, et al. Prevalence of SARSCoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020. Eurosurveillance. 2020;25(24):2001031. | |
dc.relation.references | Noh JY, Bin SY, Yoon JG, et al. Seroprevalence of anti-SARS-CoV-2 antibodies among outpatients in southwestern Seoul, Korea. J Korean Med Sci. 2020;35(33):e311. | |
dc.relation.references | Mattar S, Alvis-Guzman N, Garay E, et al. Severe acute respiratory syndrome coronavirus 2 seroprevalence among adults in a tropical city of the Caribbean area, Colombia: are we much closer to herd immunity than developed countries? Open Forum Infect Dis. 2020;7(12):ofaa550. | |
dc.relation.references | Eurofins. INgezim COVID 19 DR. Available from: https://ingenasa. eurofins-technologies.com/home-es/productos/covid19/ensayoelisa/ingezim-covid-19-dr/ [accessed 16 June 2021]. | |
dc.relation.references | Franco R, Hopenhayn M, León A. The growing and changing middle class in Latin America: an update. Cepal Rev. 2011. | |
dc.relation.references | Dodd RY, Xu M, Stramer SL. Change in donor characteristics and antibodies to SARS-CoV-2 in donated blood in the US, June–August 2020. JAMA. 2020;324(16):1677–9. | |
dc.relation.references | Reyes-Vega MF, Soto-Cabezas MG, Cárdenas F, et al. SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: a population-based seroepidemiological survey in Lima, Peru. EClinicalMedicine 2021;34: 100801. | |
dc.relation.references | Xu X, Sun J, Nie S, et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med. 2020;26(8): 1193–5. | |
dc.relation.references | Buss LF, Prete CA, Jr, Abrahim CMM, et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021;371(6526):288–92. | |
dc.relation.references | Faccini-Martínez ÁA, Rivero R, Garay E, et al. Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia. Int J Infect Dis. 2020;101:191–3. | |
dc.relation.references | Swedish Public Health Agency. Initial results from ongoing investigation of antibodies to covid-19 virus. Available from: https://www. folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/ forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-forcovid-19-virus/ [accessed 16 June 2021]. | |
dc.relation.references | Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of antiSARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313–9. | |
dc.relation.references | Bunders MJ, Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions. Immunity. 2020;53(3):487–95. | |
dc.relation.references | Figar S, Pagotto V, Luna L, et al. Community-level SARS-CoV-2 seroprevalence survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research. medRxiv. 2020; doi: 10.1101/2020.07.14.20153858. | |
dc.relation.references | Mattar S, Martinez-Bravo C, Rivero R, et al. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean. Ann Clin Microbiol Antimicrob. 2020;19(1):58. | |
dc.relation.references | Bampoe S, Lucas DN, Neall G, et al. A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals. Anaesthesia. 2020;75(12):1614–9. | |
dc.relation.references | Paolo C, Carmelo S, Marcello M. Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy. Int J Infect Dis. 2020;97: 352–3. | |
dc.relation.references | Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-tomoderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8): 2251–61. | |
dc.relation.references | European Centre for Disease Prevention and Control. Rapid risk assessment: risk of COVID-19 transmission related to the end-of-year festive season. Available from: https://www.ecdc.europa.eu/en/publicationsdata/risk-assessment-covid-19-festive-season. [ accessed 16 June 2021]. | |
dc.rights | Derechos reservados - Corporación Universitaria de Caribe - CECAR | |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.rights.coar | http://purl.org/coar/access_right/c_abf2 | |
dc.rights.license | Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | |
dc.source | https://doi.org/10.1093/trstmh/trab094 A | |
dc.subject.proposal | Asymptomatic infections | |
dc.subject.proposal | Economic conditions | |
dc.subject.proposal | Informal social controls | |
dc.subject.proposal | Public health | |
dc.subject.proposal | Seroepidemiologic studies | |
dc.subject.proposal | Social conditions | |
dc.title | SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes | eng |
dc.type | Artículo de revista | |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | |
dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |
dc.type.content | Text | |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.redcol | http://purl.org/redcol/resource_type/ART | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dspace.entity.type | Publication |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- ARS-CoV-2 in eight municipalities of the Colombian tropics.pdf
- Tamaño:
- 838.93 KB
- Formato:
- Adobe Portable Document Format
Bloque de licencias
1 - 1 de 1
Cargando...
- Nombre:
- license.txt
- Tamaño:
- 14.49 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: